Summary
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK and PD information necessary for clients’ go/no go decisions and to determine appropriate dosing ranges in Phase II studies.
Register to download
CSF Sampling
You may also be interested in:
White Paper
Favorable Regulatory Procedures In The Netherlands Phase I-IIa
The EU Clinical Trials Directive (CTD) has been fully implemented in The Netherlands. Prior to beginning a clinical trial, an identical Clinical…
View Resource
Video
Daily Diabetes Management in the Virtual World
Our speakers will be discussing how they used a Design Thinking Methodology approach for insight and prototype generation. People with both Type 1…
View Resource
Poster
Marijuana Effect on Differentiating an Opioid from Placebo During the Discrimination Phase of a Human Abuse Potential Study
Subjects of human abuse potential (HAP) studies must be able to detect liking with the investigational drug. However, many subjects recruited for HAP…
View Resource
View all related content and resources for Clinical Pharmacology
Explore Insights